A detailed history of Shay Capital LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Shay Capital LLC holds 133,258 shares of DNA stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
133,258
Previous 44,291 200.87%
Holding current value
$1.08 Million
Previous $51,000 15.69%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.28 - $1.16 $24,910 - $103,201
88,967 Added 200.87%
133,258 $43,000
Q1 2024

May 15, 2024

BUY
$1.06 - $1.67 $18,273 - $28,789
17,239 Added 63.73%
44,291 $51,000
Q3 2023

Nov 14, 2023

SELL
$1.61 - $2.54 $3,542 - $5,588
-2,200 Reduced 7.52%
27,052 $48,000
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $18,061 - $32,961
15,051 Added 105.99%
29,252 $38,000
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $23,147 - $49,987
14,201 New
14,201 $23,000
Q2 2022

Aug 15, 2022

BUY
$2.2 - $4.2 $26,505 - $50,601
12,048 New
12,048 $29,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.4B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Shay Capital LLC Portfolio

Follow Shay Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shay Capital LLC with notifications on news.